CME
Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)
Host: Mark Socinski, MD Guest: Patrick Forde, M.B.B.Ch. The optimal management of non-small cell lung cancer (NSCLC) has fundamentally changed. Targeted agents, mono and combination immunotherapy, and immunochemotherapy options continue to e